Where The Buying Ran Strongest: 11 Mid Cap Stocks At 52-Week Highs

SPY: State Street SPDR S&P 500 ETF Trust logo
SPY
State Street SPDR S&P 500 ETF Trust

A small group of mid-cap stocks is showing notable strength, but their underlying stories diverge.

On Wednesday, 11 Mid Cap stocks from the Russell 3000 reached their 52-week highs. This focused list of winners emerged while the S&P 500 has returned just +0.4% over the last month. The largest company making a new high is Edison International (EIX), with a market value of about $30.9 billion.

The central question raised by this data is what kind of strength investors are rewarding. Below is the full list of names.

Photo by ArtsyBee on Pixabay

The Biggest Names On The List

Relevant Articles
  1. XOP ETF Holds Fewer Bets Than You Think
  2. MU Vs Its Peers: A Lead With A Price Tag
  3. DGRO Is Near A High, Resist The Urge To Act
  4. TXN Keeps Climbing. Should You Climb On?
  5. Qualcomm’s AI Story Is Hot. Why Is First Solar’s Future Clearer?
  6. Is CDE Stock A Bargain Or A Trap? Mostly A Bargain

The table below shows the 10 largest of the 11 names, sorted by market capitalization, with returns over four windows:

Tickers Market
Cap
1D
% Chg
1W
% Chg
1M
% Chg
1Y
% Chg
EIX $30.9 Bil 2.8% 4.8% 12.7% 66.5%
RPRX $25.6 Bil 0.5% 4.3% 9.6% 68.2%
BBY $18.3 Bil 2.2% 2.0% 14.6% 38.9%
KIM $17.6 Bil 0.2% 4.2% 5.9% 26.6%
HST $16.8 Bil 0.2% 2.9% 1.2% 64.8%
OHI $15.0 Bil 0.0% 5.5% 12.2% 41.6%
PAG $14.1 Bil 9.9% 7.1% 22.6% 33.3%
IVZ $13.8 Bil 1.3% 0.7% 6.0% 56.3%
ARWR $12.6 Bil 19.0% 23.5% 8.2% 503.0%
SJM $12.6 Bil 2.0% 8.3% 10.1% 16.9%

A new high can reflect very different business stories.

Consider the two largest companies on the list. Edison International (EIX) is at its yearly high while trading at 8.2 times trailing earnings. The utility’s revenue grew 13.1% over the last twelve months, with an operating margin of 21.2%.

In contrast, Royalty Pharma (RPRX) also hit a new high but trades at 31.0 times trailing earnings. Its revenue grew 7.8% over the last twelve months, supported by a 67.9% operating margin. One price level can contain very different profiles of growth, margin, and valuation.

A 52-week high is a starting point for research, not an end.

Strength often persists, and a stock at its high is one that has been working. But a price is not a verdict on the future. The disciplined move is to check whether the business fundamentals earn the stock’s new level. A high price invites the question of whether the underlying revenue growth and margins justify the market’s attention.

Before chasing any name on this list, ask what the company itself expects next. Our Guidance Momentum screen surfaces the stocks whose managements just raised their own outlooks, which is the momentum that tends to have staying power.

Strength Is A Clue. It Is Not A Plan

A stock at its 52-week high has momentum on its side, and momentum is a real force. It is also the most crowded signal in the market, and the difference between a run that lasts and one that tops is always the business underneath.

Checking that business, across thousands of names, is how the Trefis High Quality (HQ) Portfolio is assembled: roughly 30 companies that pass the quality screens, rebalanced on rules. It has a track record of outpacing a benchmark that combines all major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Let the highs point; let the discipline decide.